Monohydroxylated polycyclic aromatic hydrocarbons inhibit both osteoclastic and osteoblastic activities in teleost scales.
OBJECTIVE
We previously demonstrated that monohydroxylated polycyclic aromatic hydrocarbons (OHPAHs) bound to a human estrogen receptor (ER) by a yeast two-hybrid assay, but polycyclic aromatic hydrocarbons did not have a binding activity. Therefore, the direct effect of 3-hydroxybenz[a]anthracene (3-OHBaA) and 4-hydroxybenz[a]anthracene (4-OHBaA) on osteoclasts and osteoblasts in teleosts was examined. As a negative control, 1-hydroxypyrene (1-OHPy), which has no binding activity to human ER, was used.


METHODS
The effect of OHPAHs on osteoclasts and osteoblasts was examined by an assay system using teleost scale as each marker: tartrate-resistant acid phosphatase for osteoclasts and alkaline phosphatase for osteoblasts. Changes in cathepsin K (an osteoclastic marker) and insulin-like growth factor-I (IGF-I) (an osteoblastic marker) mRNA expressions in 4-OHBaA-treated goldfish scales were examined by using a reverse transcription-polymerase chain reaction.


RESULTS
In both goldfish (a freshwater teleost) and wrasse (a marine teleost), the osteoclastic activity in the scales was significantly suppressed by 3-OHBaA and 4-OHBaA, although 1-OHPy did not affect the osteoclastic activity. In reference to osteoblasts, the osteoblastic activity decreased with both 3-OHBaA and 4-OHBaA and did not change with the 1-OHPy treatment. However, 17beta-estradiol (E(2)) significantly increased both the osteoclastic and osteoblastic activities in the scales of both goldfish and wrasse. The mRNA expressions of both cathepsin K and IGF-I decreased in the 4-OHBaA-treated scales but increased in the E(2)-treated scales.


CONCLUSIONS
The current data are the first to demonstrate that 3-OHBaA and 4-OHBaA inhibited both osteoclasts and osteoblasts and disrupted the bone metabolism in teleosts.
Suzuki
Nobuo
N
Noto Marine Laboratory, Institute of Nature and Environmental Technology, Kanazawa University, Noto-cho, Ishikawa 927-0553, Japan. nobuo@kenroku.kanazawa-u.ac.jp
Hayakawa
Kazuichi
K
Kameda
Takayuki
T
Triba
Akira
A
Tang
Ning
N
Tabata
Makoto J
MJ
Takada
Koji
K
Wada
Shigehito
S
Omori
Katsunori
K
Srivastav
Ajai K
AK
Mishima
Hiroyuki
H
Hattori
Atsuhiko
A
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D056657:Cathepsin K; D002403:Cathepsins / Q000378:metabolism; D005399:Fishes / Q000254:growth & development* / Q000378:metabolism; D006054:Goldfish / Q000254:growth & development / Q000378:metabolism; D006900:Hydroxylation; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D034582:Integumentary System / Q000254:growth & development; D010006:Osteoblasts / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D010010:Osteoclasts / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D011084:Polycyclic Aromatic Hydrocarbons / Q000737:chemistry / Q000633:toxicity*; D014874:Water Pollutants, Chemical / Q000737:chemistry / Q000633:toxicity*
D015415:Biomarkers; D011084:Polycyclic Aromatic Hydrocarbons; D014874:Water Pollutants, Chemical; D007334:Insulin-Like Growth Factor I; D002403:Cathepsins; C534130:CTSK protein, human; D056657:Cathepsin K